1-Methyl-4-phenyl-1,2,3,6-retrahydropyridine (MPTP) neurotoxicity reproduce
s many of the features of Parkinson's disease (PD). alpha-Synuclein has bee
n identified as a prominent component of the Lewy body (LB), the pathologic
al hallmark of PD. MPTP-treated primates have been reported to develop intr
aneuronal inclusions but not true Lewy bodies. We administered MPTP to babo
ons and used a monoclonal alpha-synuclein antibody to define the relationsh
ip between neuronal degeneration and alpha-synuclein immunoreactivity in th
e substantia nigra. MPTP-induced neuronal degeneration was associated with
the redistribution of alpha-synuclein from its normal synaptic location to
aggregates in degenerating neuronal cell bodies. alpha-Synuclein aggregatio
n induced by MPTP models the early stages of Lewy body formation and may be
a fundamental step in the evolution of neuronal degeneration in PD. NeuroR
eport 11:211-213 (C) 2000 Lippincott Williams & Wilkins.